Company profile for SynCore Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutical company focusing on creating values of the new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar’s experiences which have been accumulated for more than 30 years in R&D, manufacturing, and international marketing. Such ...
SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutical company focusing on creating values of the new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar’s experiences which have been accumulated for more than 30 years in R&D, manufacturing, and international marketing. Such experiences enable SynCore to build up the comprehensive pipeline portfolio for new drug development to fulfill domestic and international market needs and to consolidate the future development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
84 Chung Shan Rd., Chung Shan Village, Tung-Shan, I-Lan, 269
Telephone
Telephone
+886-3-958-6101
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
SynCore drug trial shows ‘no statistical significance’
SynCore drug trial shows ‘no statistical significance’

21 Oct 2021

// Kao Shih-ching TAIPEITIMES

https://www.taipeitimes.com/News/biz/archives/2021/10/22/2003766521#:~:text=The%20unblinding%20of%20phase%203,group%2C%20the%20drugmaker%20said%20yesterday.

Kao Shih-ching TAIPEITIMES
21 Oct 2021

http://www.biospace.com/News/amgen-acquires-medigene-ag-spinoff-catherex-for-10/403670/source=TopBreaking

Mark Terry BIOSPACE
23 Dec 2015

ABOUT THIS PAGE

Contact SynCore Biotechnology and get a quotation

SynCore Biotechnology is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Agn-Pc-004Wxe bulk with DMF offered by SynCore Biotechnology

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty